Genmab’s shares have doubled in three months after a string of cancer drug trial wins, strengthening its push to own more of the medicines it develops.
原文: https://www.cnbc.com/2026/11/03/genmab-cancer-drugs-petosemtamab.html
Last Update:
3 11 月, 2026
